Solaray CoQ10 100 mg Review

No — the panel names the form as CoQsol, not Kaneka or Kaneka QH, and nothing on the label points to Kaneka (Kaneka publishes no licensee list to check against). The molecule is structurally identical to Kaneka ubiquinone (CoQ10 is a defined compound), but the supply chain provenance differs. Solaray runs GMP-certified manufacturing and has 50 years of consistent brand reputation, so the QC discipline is real — the chain-of-custody gap is at the raw-material supplier tier, not the manufacturing tier. For buyers anchoring purchases to the trial-evidence base (Q-SYMBIO, Banach 2015 statin meta — both used Kaneka product), Solaray isn't the right pick. For buyers who value brand legacy and don't need the trial-supply-chain link, the chain-of-custody gap is less material.

Not when we checked. On Amazon US on Oct 11, 2026 the only offer for the 60-softgel bottle came from a marketplace seller at $28.00, which is $0.47 per softgel. Three Kaneka ubiquinols cost less per softgel the same day (Qunol Mega $0.36, Jarrow $0.45, NOW $0.46), and Doctor's Best ubiquinone cost $0.16. An earlier version of this review put Solaray at $18 a bottle and called it the cheaper option; at the price we read it is not. The shelf price in a health store may differ, so compare per softgel before you buy.

Not BioPerine or a surfactant — but it isn't a bare capsule either. The front label says 'Enhanced Absorption' and the panel names CoQsol in a rice-bran-oil softgel with yellow beeswax, an oil-based delivery system that helps a lipid-soluble molecule. We found no head-to-head data against Kaneka ubiquinol or BioPerine formulations, so treat it as a plausible improvement over a dry hard capsule, not a proven one. Take it with a fat-containing meal anyway: with breakfast eggs or dinner with olive oil, absorption is fine; fasted with water, you'll waste a large share of the dose. For buyers who sometimes dose fasted or with low-fat snacks, Doctor's Best (#6) with BioPerine (~30% absorption boost) or Qunol (#8) with its water-soluble surfactant carrier (~3× fasted absorption boost) are better matched.

Same dose-scaling math as other 100 mg ubiquinone products. General longevity / under-40 baseline: 1 softgel/day with breakfast eggs or dinner with olive oil — 100 mg of ubiquinone is converted to active ubiquinol endogenously. Statin users with myalgia (note: ubiquinol is the better form for this indication; consider upgrading to Jarrow #1): 2 softgels/day with dinner = 200 mg matches the Banach 2015 protocol. Migraine prophylaxis: 3 softgels/day split AM/PM with meals = 300 mg matches the Sandor 2005 protocol. One thing to count: each softgel also carries 700 mcg vitamin A (as beta carotene) and 67 mg vitamin E, so at 2-3 softgels a day add those to whatever your multivitamin already supplies.

A gelatin softgel. The listing title says 'Vegetarian Softgel Capsules' and a tile says Vegan, but the panel's other ingredients list gelatin, so it is not vegetarian or vegan — earlier versions of this review wrongly described an HPMC vegetarian capsule. The oil base (rice bran oil, yellow beeswax) is a carrier like the ones in the Jarrow, Healthy Origins and Doctor's Best softgels. If you need a genuinely vegetarian CoQ10, check the panel for gelatin before you buy.

Three specific cases. (1) Offline emergency — your local independent health store stocks Solaray but not Doctor's Best, and you need a bottle today. Solaray's offline distribution in independent stores is strong. (2) Brand legacy trust — you've been using Solaray for years and trust the 50-year track record more than newer brand positioning. (3) You specifically want the vitamin A and E that ride along in this softgel. For all three cases, Solaray is a defensible pick. For everyone else, Doctor's Best wins on its BioPerine carrier and a much lower price; neither label names its CoQ10 supplier. The cost gap is real.

Yes, for specific buyers. Solaray was founded in 1973 and has operated continuously for over 50 years under the Nutraceutical Corporation umbrella (also owns Action Labs, KAL, others). The legacy translates to: (1) consistent GMP-certified manufacturing protocols refined over decades, (2) strong relationships with independent health stores nationwide (the 'health food store brand' that owners know personally), (3) low-controversy operating history — no major recalls on CoQ10 in 50 years on market. The legacy isn't a substitute for Kaneka licensing or BioPerine absorption enhancement, but it's not nothing. For buyers who specifically value 'brand that's been here all my life' positioning over 'brand with the strongest trial-literature anchoring', Solaray has a defensible niche. It just doesn't apply to most informed buyers.

1. [1] Mortensen 2014 (Q-SYMBIO) PMID 25282031 — The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. 420 CHF patients randomised to 3×100 mg/day Kaneka ubiquinone vs placebo for 2 years — 43% reduction in major adverse cardiovascular events. The pivotal trial used Kaneka chain-of-custody that Solaray's CoQsol ubiquinone doesn't anchor to. Cited to clarify the chain-of-custody gap for trial-anchored buyers.
2. [2] Banach 2015 (statin myopathy meta) PMID 25440725 — Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Meta-analysis of 12 RCTs on CoQ10 supplementation in statin users — significant reduction in muscle symptoms at 100-200 mg/day. Cited to clarify that Solaray's ubiquinone form is a partial undershoot versus the ubiquinol products preferred for this indication.
3. [3] Zhang 2018 (ubiquinol vs ubiquinone) PMID 30302465 — Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men. Head-to-head trial of ubiquinol vs ubiquinone in older men — 2-4× bioavailability advantage for the reduced form. The reference paper defining the form-gap that Solaray's ubiquinone undershoots for 40+ buyers.
4. [4] Sandor 2005 (migraine) PMID 15728298 — Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. 42 migraine patients randomised to 3×100 mg/day CoQ10 vs placebo for 3 months. Significant reduction in attack frequency. The protocol that Solaray's 3-softgel migraine-prophylaxis dose maps to.
5. [5] Hernández-Camacho 2018 (review) PMID 29459830 — Coenzyme Q10 supplementation in aging and disease. Comprehensive review of CoQ10 supplementation across aging, cardiovascular disease, and neurodegeneration. Confirms safety and efficacy at 100-400 mg/day across multiple populations — the protocol foundation underwriting any 100 mg/day product including Solaray.